Switch to:
Alexion Pharmaceuticals, Inc. (NAS:ALXN)
Cash And Cash Equivalents
$530 Mil (As of Dec. 2013)

Alexion Pharmaceuticals, Inc.'s quarterly cash and cash equivalents declined from Jun. 2013 ($936 Mil) to Sep. 2013 ($910 Mil) and declined from Sep. 2013 ($910 Mil) to Dec. 2013 ($530 Mil).

Alexion Pharmaceuticals, Inc.'s annual cash and cash equivalents increased from Dec. 2011 ($541 Mil) to Dec. 2012 ($990 Mil) but then declined from Dec. 2012 ($990 Mil) to Dec. 2013 ($530 Mil).


Definition

Cash and cash equivalents on banks book.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Alexion Pharmaceuticals, Inc. Annual Data

Jul04Jul05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
BS_CashAndCashEquivalents 1134716795138157267541990530

Alexion Pharmaceuticals, Inc. Quarterly Data

Sep11Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13
BS_CashAndCashEquivalents 4385413598069069901,023936910530
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide